Ligand compound with cyclic peptide structure and nuclide-labeled compound and pharmaceutical composition thereof, and use thereof

WO2026056964A1PCT designated stage Publication Date: 2026-03-19SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-09-11
Publication Date
2026-03-19

Smart Images

  • Figure CN2025120691_19032026_PF_FP_ABST
    Figure CN2025120691_19032026_PF_FP_ABST
Patent Text Reader

Abstract

A ligand compound with a cyclic peptide structure as represented by formula (I) and a nuclide-labeled compound and pharmaceutical composition thereof, and the use thereof. The ligand compound can be used for diagnosing and / or treating diseases associated with abnormal cell proliferation, and exhibits high stability and good pharmacokinetic properties.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Compounds comprising fibroblast activating protein ligands and uses thereof

    CN114341158A

  • Compounds comprising fibroblast activating protein ligands and uses thereof

    CN114341159A

  • Compounds comprising fibroblast activating protein ligands and uses thereof

    CN116940585A

  • Compounds comprising fibroblast activating protein ligands and uses thereof

    CN116940586A

  • Compounds comprising a fibroblast activation protein ligand and use thereof

    EP3763726A1